Acute Toxicities and Short-Term Patient Outcomes After Intensity-Modulated Proton Beam Radiation Therapy or Intensity-Modulated Photon Radiation Therapy for Esophageal Carcinoma: A Mayo Clinic Experience
R.S. Bhangoo(Mayo Clinic Hospital), Terence T. Sio(The University of Texas MD Anderson Cancer Center), Chenbin Liu(Mayo Clinic Hospital), William G. Rule(Mayo Clinic in Arizona), Nathan Y. Yu(Mayo Clinic Hospital), T.A. DeWees(Mayo Clinic in Arizona), Michael A. Golafshar, Christopher L. Hallemeier(Mayo Clinic in Arizona), Daniel H. Ahn(Mayo Clinic Hospital), Jonathan B. Ashman(Mayo Clinic in Arizona), Staci E. Beamer(Mayo Clinic Hospital), Wei Liu(WinnMed), Sujay A. Vora(Mayo Clinic Hospital), Helen J. Ross(Rush University), Julia Ding(Mayo Clinic Hospital), Dawn E. Jaroszewski(Mayo Clinic in Arizona)
Cited by 31
Related Papers
Cholangiocarcinoma — evolving concepts and therapeutic strategies
|Nature Reviews Clinical Oncology|2017|1.7k
Futibatinib for <i>FGFR2</i> -Rearranged Intrahepatic Cholangiocarcinoma
|New England Journal of Medicine|2023|530
Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanced Biliary Tract Cancers
|JAMA Oncology|2019|472